Among gender, age, smoking history, BMI and PD-L1 expression, sarcopenia and received treatment line, gender, sarcopenia and treatment line were significant prognostic factors for PFS in the univariate analysis (all p < 0.05; Table 2). This evidence concerns the gene CD274 and sarcopenia.